Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents
- PMID: 28294048
- DOI: 10.2174/1573409913666170309145308
Computer-Aided Structure Based Drug Design Approaches for the Discovery of New Anti-CHIKV Agents
Abstract
Background: Chikungunya is a viral infection caused by Chikungunya virus (CHIKV), an arbovirus transmitted through mosquito (Aedes aegypti and Aedes albopictus) bite. The virus from sylvatic cycle in Africa mutated to new vector adaptation and became one of the major emerging and re-emerging viral infections in the past decade, affecting more than 40 countries. Efforts are being made by many researches to develop means to prevent and control the infection through vaccines and vector control strategy. On the other hand, search for novel chemotherapeutic agents for the treatment of infected patients is on. Approach of repurposed drug is one way of identifying an existing drug for the treatment of CHIKV infection.
Objective: Review the history of CHIKV nsp2 protease inhibitors derived through structure-based computer-aided drug design along with phytochemicals identified as anti-CHIKV agents.
Methods: A survey on CHIKV inhibitors reported till date has been carriedout. The data obtained were organized and discussed under natural substances and synthetic derivatives obtained as result of rational design.
Results: The review provides a well organized content in chronological order that has highly significant information for medicinal chemist who wish to explore the area of Anti-CHIKV drug design and development. Natural compounds with different scaffolds provides an opportunity to explore Ligand based drug design (LBDD), while rational drug design approaches provides opportunity to explore the Structure based drug design.
Conclusion: From the presented mini-review, readers can understand that this area is less explored and has lots of potential in anti-CHIKVviral drug design & development. of reported literature inferred that, unlike other viral proteases, the nsP2 protease can be targeted for CHIKV viral inhibition. The HTVS process for the identification of anti-CHIK agents provided a few successive validated lead compounds against CHIKV infections.
Keywords: Anti-CHIKV; Chikungunya; drug design; inhibitors; protease.; replication; targets.
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.
Similar articles
-
Chikungunya virus drug discovery: still a long way to go?Expert Opin Drug Discov. 2019 Sep;14(9):855-866. doi: 10.1080/17460441.2019.1629413. Epub 2019 Jun 14. Expert Opin Drug Discov. 2019. PMID: 31177861 Review.
-
A compendium of small molecule direct-acting and host-targeting inhibitors as therapies against alphaviruses.J Antimicrob Chemother. 2017 Nov 1;72(11):2973-2989. doi: 10.1093/jac/dkx224. J Antimicrob Chemother. 2017. PMID: 28981632 Free PMC article. Review.
-
Antiviral activities of niclosamide and nitazoxanide against chikungunya virus entry and transmission.Antiviral Res. 2016 Nov;135:81-90. doi: 10.1016/j.antiviral.2016.10.003. Epub 2016 Oct 11. Antiviral Res. 2016. PMID: 27742486 Free PMC article.
-
Discovery of Novel Peptidomimetics as Irreversible CHIKV NsP2 Protease Inhibitors Using Quantum Mechanical-Based Ligand Descriptors.Chem Biol Drug Des. 2015 Dec;86(6):1518-27. doi: 10.1111/cbdd.12621. Epub 2015 Aug 27. Chem Biol Drug Des. 2015. PMID: 26212366
-
Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus.Antiviral Res. 2013 Apr;98(1):12-8. doi: 10.1016/j.antiviral.2013.01.002. Epub 2013 Feb 1. Antiviral Res. 2013. PMID: 23380636
Cited by
-
Novel Analogues of the Chikungunya Virus Protease Inhibitor: Molecular Design, Synthesis, and Biological Evaluation.ACS Omega. 2021 Apr 14;6(16):10884-10896. doi: 10.1021/acsomega.1c00625. eCollection 2021 Apr 27. ACS Omega. 2021. PMID: 34056242 Free PMC article.
-
1,3-Thiazolbenzamide Derivatives as Chikungunya Virus nsP2 Protease Inhibitors.ACS Omega. 2021 Feb 17;6(8):5786-5794. doi: 10.1021/acsomega.0c06191. eCollection 2021 Mar 2. ACS Omega. 2021. PMID: 33681617 Free PMC article.
-
Current and Promising Antivirals Against Chikungunya Virus.Front Public Health. 2020 Dec 15;8:618624. doi: 10.3389/fpubh.2020.618624. eCollection 2020. Front Public Health. 2020. PMID: 33384981 Free PMC article. Review.
-
Small Molecule Inhibitors Targeting Chikungunya Virus.Curr Top Microbiol Immunol. 2022;435:107-139. doi: 10.1007/82_2020_195. Curr Top Microbiol Immunol. 2022. PMID: 31974761 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous